Taspoglutide

Taspoglutide is a pharmaceutical drug, a glucagon-like peptide-1 agonist (GLP-1 agonist), under investigation for treatment of type 2 diabetes being codeveloped by Ipsen and Roche.

Online Inquiry

Specification Technical Data Related Products Customer reviews and Q&A Useful Tools Publications

CAT#	10-101-176
CAS	275371-94-3
Synonyms/Alias	UNII-2PHK27IP3B
M.F/Formula	C152H232N40O45
M.W/Mr.	3339.70948
Sequence	H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Aib-Arg-NH2
Labeling Target	Glucagon-like peptide 1 (GLP-1) receptor
Application	Taspoglutide is developed for treatment of type 2 diabetes
Activity	Agonist
Areas of Interest	Metabolic Disease

CAT#	Product Name	Inquiry
10-101-267	Arg-Gly-Asp	Inquiry
10-101-291	Bradykinin 1-7	Inquiry
10-101-109	Antazoline Phosphate	Inquiry
10-101-105	Ramoplanin	Inquiry
10-101-75	CRF (human, rat) Acetate	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Source#	Synthetic
Storage	-20°C
BoilingPoint	N/A
Melting Point	N/A